User profiles for Pierre Jean Le Reste

Pierre-Jean Le Reste

GHT Rance Emeraude
Verified email at ch-stmalo.fr
Cited by 1148

Dual IRE 1 RN ase functions dictate glioblastoma development

…, N Pallares‐Lupon, K Schmit, PJ Le Reste… - EMBO molecular …, 2018 - embopress.org
Proteostasis imbalance is emerging as a major hallmark of cancer, driving tumor
aggressiveness. Evidence suggests that the endoplasmic reticulum ( ER ), a major site for protein …

Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives

J Obacz, T Avril, PJ Le Reste, H Urra, V Quillien… - Science …, 2017 - science.org
Cellular stress induced by the accumulation of misfolded proteins at the endoplasmic
reticulum (ER) is a central feature of secretory cells and is observed in many tissues in various …

Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort

…, PJ Le Reste… - Neuro …, 2015 - academic.oup.com
Background The standard of care for newly diagnosed glioblastoma is maximal safe
surgical resection, followed by chemoradiation therapy. We assessed carmustine wafer …

CD90 expression controls migration and predicts dasatinib response in glioblastoma

…, J Obacz, G Jegou, F Jouan, PJ Le Reste… - Clinical Cancer …, 2017 - AACR
Purpose: CD90 (Thy-1) is a glycophosphatidylinositol-anchored glycoprotein considered as
a surrogate marker for a variety of stem cells, including glioblastoma (GBM) stem cells (GSC)…

Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model

…, G Noel, S Zouaoui, J Guyotat, PJ Le Reste… - Journal of neuro …, 2018 - Springer
We assessed prognostic factors in relation to OS from progression in recurrent glioblastomas.
Retrospective multicentric study enrolling 407 (training set) and 370 (external validation set…

Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo

PJ Le Reste, R Pineau, K Voutetakis, J Samal, G Jegou… - Cancer Letters, 2020 - Elsevier
Glioblastoma multiforme (GBM) is the most severe primary brain cancer. Despite an aggressive
treatment comprising surgical resection and radio/chemotherapy, patient's survival post …

Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database

…, J Guyotat, B Irthum, K Janot, PJ Le Reste… - Neuro …, 2017 - academic.oup.com
Background. Anaplastic gangliogliomas (GGGs) are rare tumors whose natural history is
poorly documented. We aimed to define their clinical and imaging features and to identify …

Ventriculitis: a severe complication of central nervous system infections

…, L Dejoies, P Tattevin, PJ Le Reste - Open Forum …, 2021 - academic.oup.com
Pierre-Jean Le Reste Pierre-Jean Le Reste … David Luque-Paz, Matthieu Revest, François
Eugène, Sarrah Boukthir, Loren Dejoies, Pierre Tattevin, Pierre-Jean Le Reste, Ventriculitis: A …

Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?

…, L Bauchet, G Noel, J Guyotat, PJ Le Reste… - Journal of Neuro …, 2017 - Springer
A growing literature supports maximal safe resection followed by standard combined
chemoradiotherapy (ie maximal first-line therapy) for selected elderly glioblastoma patients. To …

Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients

…, S Peeters, J Guyotat, J Duntze, PJ Le Reste… - Radiotherapy and …, 2016 - Elsevier
Background To assess the influence of the time interval between surgical resection and
standard combined chemoradiotherapy on survival in newly diagnosed and homogeneously …